Drug Side Effects
Search
NEUROENDOCRINE CARCINOMA OF PROSTATE
NEUROENDOCRINE CARCINOMA OF PROSTATE
was reported 68 times
NEUROENDOCRINE CARCINOMA OF PROSTATE is most prevalent among patients taking these drugs:
#
Drug
Count
Frequency
0
DAROLUTAMIDE
8
0.0014
1
LAROTRECTINIB
1
0.0011
2
CABAZITAXEL
3
0.0009
3
BICALUTAMIDE
12
0.0008
4
DEGARELIX
4
0.0008
5
TRIPTORELIN
2
0.0006
6
DOCETAXEL
22
0.0003
7
DOCETAXEL ANHYDROUS
22
0.0003
8
ABIRATERONE ACETATE
12
0.0003
9
LEUPROLIDE ACETATE
17
0.0002
10
CALCIUM FOLINATE
1
0.0002
11
ETOPOSIDE
15
0.0002
12
MANNITOL
1
0.0002
13
ALISKIREN HEMIFUMARATE
1
0.0002
14
ENZALUTAMIDE
7
0.0001
15
TERAZOSIN HYDROCHLORIDE
1
0.0001
16
OLAPARIB
2
0.0001
17
APALUTAMIDE
1
0.0001
18
PACLITAXEL
8
0.0001
19
LABETALOL
1
0.0001
20
GOSERELIN
1
0.0001
21
CISPLATIN
5
0.0001
22
CARBOPLATIN
8
0.0001
23
EVEROLIMUS TABLETS
1
0.0001
24
DURVALUMAB
1
0.0000
25
ANTI-ITCH CREAM
2
0.0000
26
HYDROCORTISONE LOTION
2
0.0000
27
HYDROCORTISONE CREAM 1%
2
0.0000
28
HYDROCORTISONE ACETATE
2
0.0000
29
HYDROCORTISONE
2
0.0000
30
EVEROLIMUS
1
0.0000
31
RANITIDINE HYDROCHLORIDE
1
0.0000
32
OXALIPLATIN
1
0.0000
33
FLUOROURACIL CREAM, 0.5%
1
0.0000
34
FLUOROURACIL
1
0.0000
35
PREDNISOLONE ORAL SOLUTION
2
0.0000
36
POTASSIUM CHLORIDE ORAL
1
0.0000
37
USTEKINUMAB
1
0.0000
38
PEMBROLIZUMAB
1
0.0000
39
POTASSIUM CHLORIDE
1
0.0000
40
PREDNISONE
4
0.0000
41
CARVEDILOL
1
0.0000
42
SPIRONOLACTONE
1
0.0000
43
AMLODIPINE
1
0.0000
44
FUROSEMIDE
1
0.0000